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Abstract: Bone tissue engineering is sought to apply strategies for bone
defects healing without limitations and short-comings of using either bone
autografts or allografts and xenografts. The aim of this study was to fabricate
a thin layer poly(lactic-co-glycolic) acid (PLGA) coated beta-tricalcium
phosphate (β-TCP) scaffold with sustained release of vascular endothelial
growth factor (VEGF). PLGA coating increased compressive strength of the βTCP scaffolds significantly. For in vitro evaluations, canine mesenchymal stem
cells (cMSCs) and canine endothelial progenitor cells (cEPCs) were isolated
and characterized. Cell proliferation and attachment were demonstrated and
the rate of cells proliferation on the VEGF released scaffold was significantly
more than compared to the scaffolds with no VEGF loading. A significant
increase in expression of COL1 and RUNX2 was indicated in the scaffolds
loaded with VEGF and MSCs compared to the other groups. Consequently,
PLGA coated β-TCP scaffold with sustained and localized release of VEGF
showed favourable results for bone regeneration in vitro, and this scaffold has
the potential to use as a drug delivery device in the future.
Keywords: PLGA, β-TCP, VEGF, Scaffold, Tissue engineering

1. Introduction
Regeneration of bone defects resulting from infection, oncologic
resection, congenital malformation or traumatic fractures secondary to
aging is one of the most challengeable issues in reconstruction
surgeries during recent years. Autologous bone grafting demonstrated
high efficacy of bone regeneration, but it is limited in clinical setting
due to both its supply and morbidity in donor site. In addition,
although both allografts and xenografts are excessively used, the risk
of disease transmission is remained unknown.1
Bone tissue engineering provides promising strategies according
to which bone healing without above-mentioned shortcomings and
limitations are expected. Over the past decade, many studies have
been conducted to design biocompatible and biodegradable porous
engineered scaffolds enabling migration, adhesion, proliferation and
differentiation of osteoprogenitor cells to osteoblasts in order to
enhancement of bone defects reconstruction.2;3;4 It has been reported
that macropores diameter > 200 μm are expected to be effective in
osteoconduction,5 and those up to 500 μm can lead to vascularized
bone; also, well-interconnected structure can accelerate bone
regeneration and vascularization. Moreover, appropriate mechanical
properties mimicking those of natural bone is necessary at least in
range of mechanical strength of human cancellous bone (2–10 MPa).6;7
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β-TCP which is from the calcium phosphates family has been
extensively used in orthopedics, oral and plastic surgeries and bone
tissue engineering because of its excellent osteoconductivity, and
similarity to bone mineral ceramic phase, while the application of
porous β-TCP is limited because of the brittleness and poor mechanical
properties.8;9 Coating/composite of the bioceramic scaffolds with
biodegradable polymers like poly (lactic-co-glycolic) acid (PLGA),
which is biodegradable polymer, is used to enhance the mechanical
strength in previous studies. Moreover, in a recent study, it is
indicated that PLGA is the most suitable material for coating β-TCP
scaffolds in order to provide a more appropriate basis for further
biological responses.10;11
However, nutrition supplement of tissue-engineered nonvascularized bone grafts is one of the limitations of the success rate of
this technique. The limitation capacity of implanted cells to uptake
nutrient and oxygen and slowly ingrowth of blood vessels leads to the
necrosis of the cells especially in the central parts of the scaffolds, thus
the acceleration of a functional vascular network establishment within
newly formed construct is very important in clinical aspect of bone
regeneration. As a result, the aim of bone tissue engineering should be
based on both seeding osteogenic cells on an osteoconductive scaffold
and induction of angiogenesis to support the metabolic needs of the
cells.
In drug delivery applications, both applying polymer coating on
the drug-adsorbed surface of the bioceramic and impregnating the
drug into polymer coating are used to control the drug release
behavior.12 According to the literature, controllable releasing of
biological molecules such as fibroblast growth factor-2,13 icaritin,14
dexamethasone and bovine serum albumin,15 recombinant human
GDF-5,16 tetracycline17 and recombinant human bone morphogenetic
protein-2 (rhBMP-2)18 from β-TCP/PLGA composite scaffolds is
demonstrated in the recent studies.
However, local and systemic delivery of angiogenic growth
factors is a most common approach to enhance vascularization. Most
important angiogenic factor is vascular endothelial growth factor
(VEGF) which plays necessary roles in angiogenesis by not only
promotion of vascular endothelial cells mitosis, but also increasing the
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permeability of the vessels.19 Systemic exposure of VEGF may promote
vascularization in non-target sites and also enhance the risk of tumor
growth in distant areas. So, the release of VEGF must be sustained
and localized in the target zone. Also, the dose of VEGF is very
important. Davies et al.20 studied the continued administration of VEGF
on scaffold vascularization and reported that delivery of 150 ng·d− 1
could increase vascularization whereas administration of
1500 ng·d− 1induced transient vessel growth.
In this study we aimed to fabricate the thin layer PLGA coated
high porous β-TCP scaffold with controlled releasing of VEGF
encapsulated in PLGA. In order to achieve this goal a β-TCP scaffold
was produced and coated with a thin layer of PLGA containing of VEGF.
Finally, freshly isolated cMSCs and cEPCs were seeded on β-TCP/PLGA
scaffold and the bioactivity of released VEGF and cell proliferation and
differentiation were evaluated.

2. Experimental procedure
2.1. Preparation of β-TCP powder
In order to obtain calcium phosphate powders synthesized by
ethanol based sol-gel method, phosphorus pentoxide (P2O5, MERCK
Co.) and four watered calcium nitrate (Ca(NO3)2·4H2O, MERCK Co.)
were employed as chemical precursors for phosphorus and calcium,
respectively. Aqueous solutions of both phosphorus pentoxide 0.5 M
and four watered calcium nitrate 1.5 M in pure ethanol were prepared
separately. Then, phosphorus pentoxide solution was slowly poured
into the solution containing calcium nitrate which was stirring
vigorously with mechanical stirrer (1000 rpm). Then the resulting sol
was stirring for 30 min. For obtaining gel, through the process of
aging, the resulted transparent sol was kept in a closed container for
48 h at room temperature. After drying in oven with 120 °C the
resulted powders were calcined at 1100 °C for 3 h.
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2.2. Fabrication of β-TCP scaffolds and PLGA-coated βTCP scaffold
β-TCP scaffolds were fabricated by foam casting method in
which polyurethane (PU) foam was considered as a template. For
ceramic slurry preparation, β-TCP powder and distilled water (in ratio
of g/ml = 1) mixed in a ball mill, and carboxymethyl cellulose (CMC,
Sigma Co.), three poly phosphates (TPP, Sigma Co.) was used as
additives. Appropriate dimensions of PU foam templates were cut.
After cleaning and drying, the PU foams were immersed in the β-TCP
slurry and compressed slightly in order to improve its absorption;
subsequently, excessive slurry was removed by squeezing. The foams
were dried at room temperature for 24 h, and fired using electric
furnace (Modutemp Furnace) regarding a three stages schedule. In
order to burn out the foam, heating continued from room temperature
to 600 °C at a rate of 2 °C/min; then for sintering the ceramic, the
temperature was raised from 600 °C to 1200 °C at a same rate, and
hold at 1200 °C for 3 h.8
Poly(lactic-glycolic acid) (PLGA, ratio M/M% 75:25, Wako)
pellets were dissolved under stirring in dichloromethane (CH2Cl2,
Merck, Germany) solvent with the various concentrations of 5%, 10%
and 20% w/v respectively. β-TCP scaffolds were dipped into the PLGA
solution for 5 min, and excessive solution was removed by
centrifugation of the scaffold at 300 rpm for 1 min. The coated
scaffolds were dried under a fume hood overnight, and weighed
individually before being kept in a desiccator.

2.3. Encapsulation of VEGF within the PLGA coated βTCP scaffold
At first, 0.1, 0.5 and 3 μg of VEGF (Sigma Co.) was added to
10% w/v of PLGA solution under vigorous stirring. Then, these various
concentrations were loaded into the scaffolds as mentioned in Section
2.2.
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2.4. Scaffold characterization
2.4.1. Structure and morphology
Structure and morphology of the scaffolds were analyzed by
using scanning electron microscope (SEM, Zeiss, DSM 940A, Germany)
at an operating voltage of 15 kV.
By using the image analyzer software (ImageJ 1.44 p), the
dimensions of at least 100 pores randomly selected from the samples
were measured to obtain the mean pore sizes of β-TCP scaffolds
before and after PLGA coating. The below formula determines the
porosity of the scaffolds:

The weight of the scaffold divided by the volume of it, is equal
with bulk density. Electronic balance and a digital electronic
micrometer were used to measurement of the weight and the
dimensions of each sample, respectively. The theoretical density of βTCP is 3.156 g/cm3, and 20 scaffolds of each group were used for
determination of the porosity.

2.4.2. X-ray diffraction (XRD)
XRD measurement of the sintered scaffolds was performed by
X-ray diffraction (XRD, D/MAX 5000, Siemen-Brucker) which had an Xray source of Cu Kα of 50 kV and 200 mA. All X-ray spectra were
referenced to pure silicon (99.95%) as an external standard.

2.4.3. Mechanical properties
Uniaxial compression tests were performed using a HCT-25/050
Zwick/Roell mechanical tester with a 5 kN load cell at 25 °C. The βTCP and β-TCP/PLGA at various concentrations were compressed as
per ASTM standard (ASTM D5024-95a),22 and compressive strength
were recorded. The crosshead speed was set at 1 mm/min, and
loading was applied until the scaffold cracked. The dimensions of all
samples were measured at four places in the samples by a digital
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electronic micrometer and averaged. All experiments were performed
for 10 independent runs.

2.4.4. Kinetic of VEGF release
The VEGF concentration was determined by the enzyme-linked
immunosorbent assay ELISA kit. Quantizing ELISA kit (R&D Systems)
was utilized according to the manufacturer's instructions. Briefly, VEGF
loaded scaffolds were immersed in 25 ml phosphate buffer solution
(PBS) and incubated at 37 °C, the concentration of VEGF in each
sample was then measured at 0, 8, 24, 48, 72, 120, 168 and 240 h
after incubation by compared with standards of known concentration
and positive and negative controls. The concentration of VEGF was
calculated as nanogram per milligram total protein. Based on the
resealing amount and previous study20 the 3 μg amount of VEGF was
selected for cell culture assay.

2.5. In vitro biocompatibility
2.5.1. Monolayer (2D) cell culture
The present study was conducted in accordance with the
approval of the Institutional Animal Care and Use Committee of the
Tehran University of Medical Sciences, and conformed to standards of
Association for Assessment and Accreditation of Laboratory Animal
Care. Bone marrow aspirate (about 10 ml) of humerus of mongrel
dogs with average weight of 20 to 25 kg was drawn, and collected into
a 50-ml tube containing 7500 unit's heparin.

2.5.2. Isolation and characterization of canine mesenchymal
stem cells (cMSCs)
The cMSCs were isolated according to the literature with some
modifications.21 Polystyrene 72 cm2 flask containing Dulbecco modified
Eagle medium (DMEM; Gibco-BRL, Life Technologies, Grand Island,
NY) supplemented with 15% fetal bovine serum (FBS; Dainippon
Pharmaceutical, Osaka, Japan) and 100 μg/ml penicillin-streptomycin
(Gibco-BRL, Life Technologies) was used to culture bone marrow
suspensions. After 2 days, non-adherent cells were removed by both a
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series of phosphate buffered saline (PBS) washing and subsequent
medium changing. Adherent cells were expanded as monolayer culture
at incubation temperature of 37 °C containing 5% CO2 in 95%
humidity. Medium was changed every two days.

2.5.3. Differentiation ability of isolated cMSCs
Alizarin red staining and oil red staining were used for passage 3
cMSCs cells cultured for 3 weeks in the osteogenic, adipogenic, and
chondrogenic differentiation mediums, respectively. Mediums were
changed twice per week. The osteogenic differentiation medium
contained the control medium supplemented with 0.2 mM ascorbic2phosphate (Sigma, St. Louis, MO), 10 mM Na-b-glycerophosphate
(Sigma Co.), and 10− 8 M dexamethasone (Sigma). The adipogenic
differentiation medium contained the control medium supplemented
with 0.2 mM ascorbic3 phosphate (Sigma, St. Louis, MO), 100 μM
indomethacin (Sigma Co.), and 10− 5 M dexamethasone (Sigma). The
chondrogenic differentiation medium contained the control medium
supplemented with 10 ng TGF-β3 (Transforming Growth Factor-β3,
Sigma), 10 ng BMP-6(Bone Morphogenetic protein-6, sigma Co.),
50 ng ITS + premix (Insulin-Transferin-Selenium, Sigma) and 5.35 mg
Bovin Serum Albumin (Sigma). After 3 weeks, cell layers were washed
twice with PBS, fixed with 4% formalin for 15 min, and then washed
with distilled water. Subsequently, cells were incubated for 2 min with
either alizarin red or oil red, and evaluated by light microscope.

2.5.4. Cell isolation of cEPCs
The canine EPCs were isolated by using a modification of a
method,23 accordingly, 5 ml of bone marrow was centrifuged with Ficoll
at 1500 rpm for 30 min. The isolated cells were washed twice with
PBS. 1 ml of growth medium consist of EGM-2 BulletKit medium
(Clonetics, San Diego, CA) supplemented with 5% fetal bovine serum
(FBS) was used for cell culture and placed into an incubator with 37 °C
and 5% CO2 for 3 days. The medium was changed every 3 days. The
confluent cells were trypsinized with tryosinazer/EDTA and re-plated at
6 × 104 cells/cm2.
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2.5.5. Cell culture and cell seeding
The scaffolds with dimensions of 10 ∗ 10 ∗ 10 mm3 were
decontaminated by soaking them three times in 70% ethanol for
15 min, then rinsed three times with potassium phosphate buffer
solution (PBS) for 15 min before drying overnight under a sterilized
hood. The sterilized scaffolds were sealed in a 24-well plate and kept
in a refrigerator at 4 °C for later use. Before cell loading, the scaffolds
were washed with PBS.
The suspensions of 5 × 105 passage 3 cMSCs in 25 μl DMEM
medium were prepared and were placed on the top surfaces of the
scaffold cubes located in a 12-well culture plate. Before the cultures
were provided with the medium, they were pre-incubated at 37 °C for
2 h during which the drop disappeared owing to its penetration into
scaffold porosity. The cultures were provided with DMEM containing
15% FBS, and antibiotics were loaded over the scaffolds. They were
incubated for 15 min at 37 °C. After that, the medium containing the
non-adhering cells was removed, rinsed once again, and incubated for
another 15 min at 37 °C. This procedure was repeated three times.
Then, the scaffolds were transferred to another well.
For differentiation assays the cultures were provided with DMEM
containing 50 μg/ml ascorbic acid 2-phosphate (Sigma; USA), 10 nM
dexamethasone (Sigma, USA) and 10 mM β-glycerol phosphate
(Sigma; USA), 100 IU/ml penicillin and 100 μg/ml streptomycin. All
cultures were incubated at temperature of 37 °C in an atmosphere of
5% CO2.

2.5.6. Cell morphology, penetration and attachment
Samples were immediately washed three times with PBS after
growth medium was pipetted out. Then they were fixed with a 3%
glutaraldehyde solution, soaked in an osmium tetroxide solution for
1 h, and dehydrated through a series of ethanol solutions with graded
concentrations, followed by two changes of 100% amyl acetate for
15 min each. The scaffolds were dried with the use of supercritical
point dryer (Denton Vacuum critical point dryer), and cell morphology
and attachment were evaluated by SEM. For evaluation of cell
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penetration into the scaffold, cross-sections of scaffolds were used to
indicate the depth of cell penetration.

2.5.7. MTT assay
Cell proliferation was analyzed by using [3-(4,5-dimethylthiazol2-yl)-1,5-diphenyltetrazulium bromide] (MTT, Sigma, USA)
mitochondrial reaction. This assay was based on the ability of live cells
to reduce a tetrazulium-based compound, MTT, to a purplish formazan
product. Briefly, 5 × 105 cEPCs or cMSCs cells were cultivated in
composite scaffolds for a period of 2 weeks. Scaffold/cells constructs
either from day 7 or 14 of 3D culture were then washed with PBS,
transferred into new 24-well plates containing 5:1 ratio of media and
MTT solution (5 mg/ml in PBS), respectively and incubated for 2 h at
37 °C. After removing the solution, 0.5 ml of extraction solution
(dimethylsulphoxide: DMSO) was added. The constructs were washed
extensively by pipetting out repeatedly to allow total colour release.
The absorbance of the supernatant was read by a microplate reader
(BioTekEL × 800, USA) at 540 nm. Cell number was determined
through a standard curve which was established by using a known
number of cells counted by a Neubauer-counting chamber.

2.5.8. Activity of VEGF released from scaffolds
To determine the biological activity of VEGF at the dose of 3 μg
released from the BTCP/PLGA scaffolds, a cEPCs proliferation assay of
7th day was carried out.

2.5.9. Real-time polymerase chain reaction (real time-PCR)
Total RNA was extracted from the collected cells by using the
TRIzol reagent (Invitrogen, Germany), RevertAidTM H Minus First
Strand cDNA Synthesis Kit (Fermentas, Canada) was used to cDNA
synthesis and real-time PCR reactions were performed in 96-well
optical reaction plates in a 7500 real-time PCR system (Applied
Biosystems, USA). In each PCR reaction, 12 ng of cDNA and
corresponding primers (Table 1) was mixed with 1 × SYBR® Green
PCR Master Mix (Applied Biosystems, USA) in a total volume of 20 μM.
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Table 1. Sequences of primers and RT-PCR conditions.
Name

Size bond

Coll1

293 bp

RUNX2

118 bp

OSTEOCALCIN

195 bp

KDR

275 bp

VEGF

391 bp

vWF

150 bp

Sequence
F: 5′ CTA CCT ACC ACT GCT AGA AC 3′
R: 5′ TGA AAC AGA CTG GGC CAA CG 3′
F: 5′ ATG ACA CTG CCA CCT CTG A 3′
R: 5′ ATG AAA TGC TTG GGA ACT GC 3′
F: 5′ GGC AGC GAG GTA GTG AAG AG 3′
R: 5′ CAG CAG AGC GAC ACC CTA GAC 3′
F: 5′ AAG TAT GTG ACC CCA AAT TCC 3′
R: 5′ AGA ACA ACA CTT GAA AAT CTG 3′
F: 5′ CTA CCT CCA CCA TGC CAA GT 3′
R: 5′ CCT CGG CTT GCT ACA TTT TT 3′
F: 5′ CAT TCA GCT AAG AGG AGG AC3′
R: 5′ TTG TGT TCA TCA AAG GGT GG 3′

2.6. Statistical analysis
Data were analyzed by SPSS 21.0 and reported as mean and
standard deviation. If it was necessary, a two-tailed student's t-test
was used for comparing the results between the scaffolds.

3. Results
3.1. Structural and mechanical characteristics of the
scaffold
Fig. 1 shows the XRD patterns of the sintered synthesized β-TCP
powder. As it can be seen in this figure, the main characteristic peaks
of β-TCP are the major phase (β-TCP = 77.9%, HA = 20.4% and
CaO = 1.7%).

Fig. 1. XRD patterns of the sintered synthesized β-TCP powder.
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The β-TCP porous scaffolds were fabricated by replicating the
porous structure of the PU foams. The scaffolds, like the PU foams,
had a highly interconnected structure, with open macropores (Fig. 2A).
The average pore size of the macro-pores of the scaffolds was about
500 μm, estimated by the macro-pore sizes taken from the SEM (Fig.
2B and C). It was observed that the β-TCP scaffolds had more cracklike defects on and within the ceramic struts than those coated with
PLGA. (Fig. 2D–F) However, the crack-like defects in the β-TCP struts
could be filled with the polymer after the polymer solution dipping plus
centrifugation. The β-TCP scaffolds when coated with PLGA at low
concentration of 5% (Fig. 2D) and 10% (Fig. 2E) is covered partially
with PLGA and maintains the initial framework structure. Whereas the
increase of PLGA concentration to 20%, more surface of β-TCP scaffold
gets covered with PLGA coating, the stems becomes thicker and some
pores can partially be clogged, as shown in Fig. 2F. The total porosity
of the β-TCP scaffolds was determined to be approximately 84.23%.
The macroporosity of the scaffolds after infiltration and coating with
the various concentration of PLGA was slightly decreased due to the
observed thin polymer coating present on the strut surfaces, the
macro-pores were not made significantly smaller by the polymer
coating (Fig. 3A).

Materials Science and Engineering: C, Vol 69 (December 1, 2016): pg. 780-788. DOI. This article is © Elsevier B.V. and
permission has been granted for this version to appear in e-Publications@Marquette. Elsevier B.V. does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Elsevier B.V.

13

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Fig. 2. SEM micrographs of β-TCP without coating (A–C) and with coating at
concentration of 5% PLGA (D), 10% PLGA (E) and 20% PLGA (F).

Fig. 3. VEGF release amount from the scaffolds encapsulated with 0.1, 0.5, and 3 μg
of VEGF.

Compression testing was performed on both the β-TCP scaffolds
and the β-TCP scaffolds coated with the different concentration PLGA
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polymer. It was found that the β-TCP scaffolds were able to withstand
average compressive 0.42 MPa, while those coated with 5%, 10% and
20% PLGA showed a compressive strength of 3.10, 4.95 and
6.62 MPa, respectively (Fig. 3B). Obviously the compressive strength
of the scaffolds coated with PLGA was significantly higher than those
without the PLGA polymer coating, and were also comparable to that
of human cancellous bone (2–10 MPa).6
Also, the toughness of the scaffolds after and infiltration and
coating with the various concentration of PLGA has been given in Table
2. As it can be observed in this table, with increasing the PLGA
concentration, the toughness increased.
Table 2. The toughness of the scaffolds after infiltration and coating with the
various concentration of PLGA (p value < 0.05).
Sample
β-TCP (PLGA 0%)

Toughness (MPa)
0.06 ± 0.004

PLGA 5%

0.94 ± 0.03

PLGA 10%

1.73 ± 0.11

PLGA 20%

2.18 ± 0.17

According to the mechanical properties test and SEM
observations, the optimum PLGA concentration for biological
assessment and VEGF releasing was 10% w/v.

3.2. The release of VEGF from PLGA-coated β-TCP
scaffolds
The release kinetics for VEGF incorporated was subsequently
analyzed using specific ELISA kit. VEGF was released from β-TCP
scaffolds coated with PLGA, VEGF composition coating including an
initial burst release followed by a relatively slow sustained release. An
initial burst in the first 24 h was around 2.17, 14.82, and 59.64 ng/ml
for the samples encapsulated with 0.1, 0.5, and 3 μg of VEGF,
respectively. Then the protein release was sustained during the next
10 days. The average release amount was 6.87, 70.11 and
165.92 ng/ml, respectively. The release amount was related to the
loading concentration, that is, larger release amounts are for higher
initial loading concentrations of VEGF (Fig. 4). The result showed that
the protein release was at almost the same rate, for all scaffold during
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10 days. In contrast, VEGF release from the scaffolds with only PLGA
coating were significantly different and burst in nature. Moreover,
about 90% of loaded VEGF was released within the first 24 h.

Fig. 4. The macroporosity (A) and compressive strength (B) of the scaffolds after
infiltration and coating with the various concentration of PLGA.

3.3. Characterization of cMSCs and cEPCs
Formation of a number of colonies consisting of a few adherent
fibroblastic cells was demonstrated regarding regularly observations of
bone marrow cell cultures with a phase contrast invert microscope.
The colonies had grown till 10 days after which fibroblastic cells
covered all the available surfaces of the culture dishes. Passage 3
fibroblastic cells were used to differentiate into osteoblasts in
monolayer culture. After 3 passages, MSCs morphology changed from
fusiform monolayer to multilateral shaped. Moreover, multilayer small
colonies and EPCs demonstrated the characteristic cobblestone
morphology.
It was noticed that higher proliferation rate was observed even
after passages 4 or 5. According to the flow cytometry analysis, bone
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marrow stromal cells consist of mesenchymal (positive for CD90, CD44
and negative for CD146, CD34, CD45), endothelial (positive for CD34,
VEGFR2, and CD45 and negative for CD133 and CD146), and
hematopoietic (positive for CD45) lineages.
Although most hematopoietic cells were lost after 7 days, the
similar proportion of cells with mesenchymal and endothelial
phenotypes was observed. For instance, in mesenchymal-lineage cells,
the percentage of CD90 and CD44 was 95.5% and 94%, respectively,
whereas in endothelial- lineage cells, the percentage of CD34 and
CD45 was 17% and 1.35% respectively. After passage 3 EPCs, in
endothelial progenitor-lineage cells, the percentage of CD34 and
VEGFR2 was 72.5% and 64.8% respectively, whereas the percentage
of CD133 and CD 146 was 18.9% and 16.2%, respectively.
A strong alizarin red staining demonstrated the ability of freshly
isolated MSCs to deposit abundant mineralized matrix when cultured in
osteogenic medium for 3 weeks. Furthermore, as a strong oil red and
safranin staining were indicated, MSCs were able to differentiate
toward the adipogenic and chondrogenic lineage when cultured in
adipogenic and chondrogenic medium, respectively.

3.4. Initial cell penetration into and attachment onto
the PLGA-coated β-TCP scaffolds
Since cell suspension was added drop-wise to the surface of the
scaffolds for seeding of MSCs and EPCs, the cells were not
homogeneously seeded across the surface of the scaffolds. With the
use of cross-sections of the scaffolds, the penetration of the cells into
the scaffolds was investigated. According to SEM observations (Fig.
5A), the cells could penetrate to a depth of 5.5 mm with adding a drop
in one side, density of cells was not homogeneous along the depth
direction, for instance, even though cells were most plentiful on the
surface, the cell density gradually diminished with regard to increasing
the depth. Due to the highly interconnected pores of the β-TCP
scaffolds coated with PLGA, significant cell penetration was
demonstrated. Cells retaining spindle morphology was revealed 7 days
after culture of MSCs on the scaffolds (Fig. 5B). Where osteoblast
projections and pseudopodia were evident, fibrous extracellular matrix
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(ECM) was observed between cells. After a week of culture, SEM
images indicated that the scaffolds were entirely covered with a layer
of EPCs (Fig. 5C). High cell-to-cell contact and a typical cobblestonelike appearance was retained by EPCs. Moreover, pseudopodia
extensions were observed on the cells surface (Fig. 5D). Cell adhesion,
spread and proliferation on the scaffolds indicated normal cell
metabolism; therefore, β-TCP scaffolds coated with PLGA showed
favourable biocompatibility in vitro.

Fig. 5. SEM micrograph of MSCs (A and B) and EPCs (C and D) seeded on the
scaffolds.
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3.5. Cell proliferation and activity of VEGF released
from scaffolds
The viability of cells grown on the scaffold was determined by
MTT assay. There were no statistical differences between the β-TCP
and β-TCP scaffolds coated with PLGA (10%) (p > 0.05) (Fig. 6A).

Fig. 6. Proliferation of MSCs on the β-TCP and β-TCP coated with PLGA scaffolds (A)
and EPCs on the β-TCP coated with PLGA scaffolds with and without VEGF (B) at
7 days by MTT assay.

Following demonstration and confirmation of the release of
VEGF from the β-TCP scaffolds coated with PLGA, the bioactivity of the
released VEGF was determined by its proliferative induction of cEPCs in
vitro. Cell number as determined by MTT assay at day 7 conclusively
indicated that releasing of VEGF into the medium from the β-TCP
scaffolds coated with PLGA statistically increased the proliferation of
cEPCs in culture (p < 0.05) (Fig. 6B).
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3.6. Cell differentiation
To thoroughly examine and determine the level of osteogenic
differentiation and vascularization in the different groups, real timePCR analysis was performed in each groups (PLGA coated β-TCP with
and without VEGF) (Fig. 7). A culture of MSCs on the VEGF loaded
scaffolds demonstrated the highest expression of the osteogenic
markers (p < 0.05). The scaffolds loaded with VEGF and MSCs showed
a statistical increase in expression of COL1 and RUNX2 compared to
the other groups (p < 0.05).

Fig. 7. Real time-PCR analysis for PLGA coated β-TCP with and without VEGF.

Twenty-one days after cultivation, we observed a highest
expression of vWF and VEGFR2 gens in the scaffolds that released
VEGF and were loaded with MSCs (p < 0.05) in comparison to the
scaffolds loaded with MSCs.

4. Discussion
Bone tissue engineering aims to use osteoconductive scaffolds
together with delivery of osteogenic cells and biological factors. The
Scaffolds play a key role in bone regeneration and should have both an
interconnected pore structure and good mechanical properties. The
scaffold also can be used as delivery vehicle of growth factors. Due to
high osteoconductivity and biodegradability of β-TCP which is a
calcium phosphate ceramic, it has been used in different clinical
situations for bone defects regeneration.24;25 In the present research,
we fabricated a 3D highly interconnected porous PLGA coated β-TCP
scaffold with significantly enhanced mechanical strength as delivery
vehicle of VEGF, and demonstrated that its releasing of VEGF
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significantly increased both proliferation and differentiation of MSCs
and EPCs, and highly expressed osteogenic markers.
The β-TCP porous scaffold was fabricated with template casting
method with PU foam. The scaffold had a highly interconnected
structure; with the average pores size of about 500 μm. The previous
studied has showed that the pore size of about 200 μm and greater is
accelerate osteogenesis and the pore size of about 500 μm and greater
is good for vascularization. However, the major problem of highly
porous β-TCP is poor mechanical properties, the polymer coating
expected to improve the mechanical property of the brittle β-TCP.26 In
our study a β-TCP/PLGA scaffold with enhanced mechanical strength
and highly porous structure were fabricated. Coating with PLGA leads
to increase of compressive strength of the β-TCP scaffolds from
0.42 MPa to 3.10, 4.95 and 6.62 MPa for 5%, 10% and 20% PLGA
coatings, respectively. Increasing of PLGA concentration resulted in the
increase of compressive strength but it was shown that in 20% PLGA
concentration some pores was clogged as shown in Fig. 2F. PLGA
impregnation leads to fills or blunt the flaw of β-TCP template and
increase of mechanical strength. The presence of microcrack of β-TCP
template is responsible for poor mechanical strength. Pezzoti and
Asmus revealed that ductile polymer ligament could be stretched and
consume energy during propagation of microcrack. Moreover, PLGA
coatings increased mechanical strength of 3D porous β-TCP scaffold in
that of human cancellous bone range (2–10 MPa).6 In consistent with
our study, Kang et al. demonstrated enhanced mechanical strength of
3D porous β-TCP scaffold by PLGA (10 wt%) coating;8 however, their
scaffold was fabricated by a template-casting technique used
templates comprised of paraffin bead. Also, Miao et al. demonstrated
that PLGA coated hydroxyapatite (HA)/β-TCP scaffolds fabricated by a
polyurethane foam replica method showed significant increase in
mechanical strength (0.6 MPa) compared to HA/β-TCP scaffolds
(0.05 MPa).9
The total porosity of the β-TCP scaffolds was determined to be
approximately 86.87%. The macroporosity of the scaffolds after
infiltration and coating with the various concentration of PLGA was
slightly decreased due to the observed thin polymer coating present on
the strut surfaces; however, the macropores were not made
significantly smaller by the polymer coating. The coating of PLGA was
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result of the decrease in porosity by approximately 2% and it was
consistent with the previous study by Kang et al.8
The biocompatibility of β-TCP and β-TCP/PLGA scaffold was
evaluated with MSCs and EPCs attachment and proliferation. Our
results revealed that MSCs could be attached and proliferated on βTCP scaffold with and without PLGA which is in consistent with the
previous study.8 The number of MSCs was significantly higher in
scaffold groups than positive control, but there were no significant
differences between the scaffolds. SEM observation of cross-sections of
the scaffolds showed that the cells could penetrate non-homogenously
to a depth of 5.5 mm. The results were consistent with the study by
Miao et al. according to which bone marrow stromal stem cells
(BMSCs) penetration to a depth of 4.5 mm was reported into a HA/βTCP coated with PLGA.9
The loading capacity of pure β-TCP is limited, and weak physical
adsorption is responsible for loading. Our results showed that
encapsulation of VEGF in PLGA coating could be a suitable way to
control of loading amount, and it was controlled by changing the VEGF
concentration in PLGA coating. Localized and sustained delivery of
VEGF permits prolonged exposure of regenerating tissue to efficient
doses to enhance vascularization, however high levels of VEGF can
lead to abnormal vascular function and vascular tumor growth. VEGF
should be released as sustained manner during healing process of
bone.
To investigate the mitogenic potential of VEGF released from
PLGA coated β-TCP scaffold, proliferation of EPCs cultured on the
scaffolds was indicated after 7 days. According to the study conducted
by Silva et al., the rate of endothelial cells proliferation reached a
plateau at 50 ng/ml, which demonstrated proliferation of cells 60%
more than compared to without discretion of VEGF.27 They also
indicated by the 3D sprout assay that higher numbers of sprouts were
revealed when cells exposed to higher doses of VEGF in the early days.
The release profile from PLGA in 0.5, 1 and 3 μg concentration
of VEGF displays a sustained manner up to 14 days, nevertheless
there was a significantly smaller amount of VEGF released from 0.5
and 1 μg compared to concentration of 3 μg. Sustained release of
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VEGF is due to distribution of VEGF into polymer coating whereas the
initial burst release is due to binding of VEGF to PLGA surface. The
bioactivity of released VEGF is very important; our results showed that
the dose of 750 ng VEGF per each PLGA (10 wt%) coated β-TCP
scaffolds leads to significantly increasing the number of EPCs and
MSCs. Using a range of 250 ng to 3 μg VEGF per each construct is
reported for bone tissue engineering in the literature.28 The studies in
animal models have revealed that the inhibition of however the main
VEGF receptors expressed on endothelial cells, there are many VEGF
receptors expressed on osteoblasts.19
After confirmation of effects of VEGF on MSCs and EPCs
proliferation we examined the osteogenic and angiogenic
differentiation ability of cells seeded on β-TCP/PLGA scaffolds with and
without VEGF. This study indicated the sustained release of VEGF
significantly increased marker of osteogenesis and angiogenesis.
VEGF expression and low concentration of oxygen lead to an
upregulation of BMP-2. This pathway may play a significant role in
bone repair. VEGF is a significant therapeutic agent for bone
regeneration which not only promotes angiogenesis but also play an
important role in bone growth and repair.29
In summary, it is enticing to hypothesize that the degree of
differentiation and thus the maturity of EPCs could play a crucial role
in their effect on MSCs osteogenic differentiation.30 This is
demonstrated by the work of Loibl et al. that determines EPC
differentiation into mature EC by direct cell-cell contact with MSCs.31
Additionally, various studies ascertained the presence of PL could
promote cell proliferation of EPC in EPC-MSC co-culture supports a
pericyte-like differentiation of MSCs in both MSC and EPC-depleted
MSC populations.31;32 Furthermore, it was displayed that the
incorporation of MSC could promoted stable neovascularization in EPCderived tube formation in vivo.33 Still, the perfect proportion of EPC for
early neovascularization is questionably discussed in the literature.
Duttenhoefer et al. revealed the ratio of 50/50 of MSC and EPC is
ideal.32 These obtained results were confirmed by in vivo study, where
the highest number of vessels in the center of scaffolds, implanted
subcutaneously in the mice, was determined in 50% MSC + 50% EPC
proportion.34 In actuality, Fu et al., ascertained that the ratio of 75%
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EPC + 25% MSC in modified calcium polyphosphate constructs
displayed the highest expression of osteogenic and angiogenic
markers, while the level of EPC maturation still stays indistinct.35
Duttenhoefer et al. found that absence of EPCs in MSC
population enables higher osteogenic gene expression and matrix
mineralization and thus may prompt prior new bone formation.
Nevertheless, the utilization of cells in bone tissue engineered scaffolds
requests the support of a functional blood supply. In this way, our
obtained results may cause to novel approaches in cell seeding to
develop vascularized bone tissue engineered scaffolds, such as
specific, organized, or time dependent seeding of various cell types.
Finally, further evaluations on the mechanisms by which
CD34+/CD133+ EPC effect MSC osteogenic differentiation as well as the
effect of EPC maturation in this approach are mandatory.
It is important to point out, although the direct mechanisms of
tubular-like structure formation in co-culture of MSCs and EPCs are
still obscure, it has been exhibited that mature endothelial cells and
osteoblasts influence proliferation, as well as differentiation of each
other.32 It has been reported that growth factors such as BMP-2 and
IGF released by endothelial cells influence osteoblast proliferation and
differentiation.36;37 Consequently, osteoblasts can increment
endothelial cell viability, proliferation and angiogenesis, by releasing
high levels of VEGF.38 Also, Duttenhoefer et al. revealed that without
MSCs, number of EPCs reduced after 7 days in 3D culture which it is
consistent with the study of Hofman et al.39

5. Conclusion
PLGA coated β-TCP scaffold demonstrated desired results for
bone tissue engineering since it showed appropriate mechanical
strength and biocompatibility with sustained and localized release of
VEGF which affect proliferation rate of EPCs. This scaffold may be
utilized as a drug delivery device for other growth factors and
biomolecules in the future.
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